PMC:7736111 / 55-779 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":16,"end":21},"obj":"Disease"},{"id":"19","span":{"begin":94,"end":104},"obj":"Species"},{"id":"20","span":{"begin":147,"end":155},"obj":"Species"},{"id":"21","span":{"begin":181,"end":189},"obj":"Species"},{"id":"22","span":{"begin":498,"end":506},"obj":"Species"},{"id":"23","span":{"begin":698,"end":706},"obj":"Species"},{"id":"27","span":{"begin":81,"end":90},"obj":"Disease"},{"id":"28","span":{"begin":138,"end":146},"obj":"Disease"},{"id":"29","span":{"begin":489,"end":497},"obj":"Disease"},{"id":"30","span":{"begin":549,"end":557},"obj":"Disease"},{"id":"31","span":{"begin":683,"end":697},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D003643"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:9606"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D007239"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:C000657245"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C000657245"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:C000657245"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. Further, adaptive immune response during COVID-19 is heterogeneous and poorly understood. At the same time, some studies suggest activated T and B cell response in severe and critically ill patients and the presence "}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":23,"end":31},"obj":"Sentence"},{"id":"T4","span":{"begin":32,"end":156},"obj":"Sentence"},{"id":"T5","span":{"begin":157,"end":304},"obj":"Sentence"},{"id":"T6","span":{"begin":305,"end":507},"obj":"Sentence"},{"id":"T7","span":{"begin":508,"end":597},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. Further, adaptive immune response during COVID-19 is heterogeneous and poorly understood. At the same time, some studies suggest activated T and B cell response in severe and critically ill patients and the presence "}